Current issues with platelet transfusion in patients with cancer.
about
Thrombopoietin mimetics for patients with myelodysplastic syndromesMetalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cellsHematology in palliative medicine.A rationally designed agonist antibody fragment that functionally mimics thrombopoietinHaematopoietic stem and progenitor cell-targeted therapies for thrombocytopenia.Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.Effects of high-yield thrombocytapheresis on the quality of platelet products.Thrombocytopenia in patients with myelodysplastic syndromes.Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet releaseUnique in vitro and in vivo thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca(++)-independent protein kinase C isoform agonist.Management of thrombocytopenia due to liver cirrhosis: a reviewThe role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Role of interleukin-6 in differentiating interleukin-11 induced fever and early bacterial infection.Thrombopoietin mimetics for patients with myelodysplastic syndromes.
P2860
Q24198060-FAB3D840-1C9C-4058-9A8C-1A0EF7464DCCQ30483213-C510F135-FD82-427F-9F36-6FE01351B665Q33364223-1E86A60F-6833-4FDA-81DB-82B16F530535Q33372657-350539DE-C3D5-4B17-A79C-751CB2D9CC8DQ33372720-1F9A4D1C-0447-41B1-BE6F-F8DC2956985DQ33375060-C6128D7E-7D5D-4E6E-842C-5FECC894A44EQ33377710-8C668848-2007-4080-A8ED-7ADE243DD9E6Q33390639-9EC6D335-D6EE-43FC-8384-467CFEFC3CC5Q33393835-A49D8971-009D-4829-A5DE-BF8DCADE70ACQ33405086-394C064F-64A8-4506-A819-CF4812035AF9Q33413924-87339234-C364-434A-82C7-6EFB97146B18Q33414386-A44487C1-9CDE-4ACB-804D-2CA08DCE30ACQ33416575-69FF51A6-FF41-45FF-8089-AC16F50322ABQ33418708-D3D8DD11-9890-4DE8-9363-E35A50927560Q33426772-2BFC4451-9714-4994-AD1F-C74A36748BF0Q33427048-ABED7639-C2F9-4C4A-8C77-361555A4EB7CQ40212712-05C13E0C-5992-48B7-8FE6-174A2339028CQ47550396-1483CEB1-8C55-418D-A369-A0F5E6218EA4
P2860
Current issues with platelet transfusion in patients with cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Current issues with platelet transfusion in patients with cancer.
@ast
Current issues with platelet transfusion in patients with cancer.
@en
Current issues with platelet transfusion in patients with cancer.
@nl
type
label
Current issues with platelet transfusion in patients with cancer.
@ast
Current issues with platelet transfusion in patients with cancer.
@en
Current issues with platelet transfusion in patients with cancer.
@nl
prefLabel
Current issues with platelet transfusion in patients with cancer.
@ast
Current issues with platelet transfusion in patients with cancer.
@en
Current issues with platelet transfusion in patients with cancer.
@nl
P1476
Current issues with platelet transfusion in patients with cancer.
@en
P2093
McCullough J
P356
10.1016/S0037-1963(00)90047-7
P433
P577
2000-04-01T00:00:00Z